Remus Pharmaceuticals Limited — Board Meeting, 07-07-2025: Outcome of Board Meeting

Remus Pharmaceuticals has announced a board meeting on July 7, 2025, approving a 1:1 bonus share issue, doubling the equity base from 58.92 lakh shares to 1.18 crore shares. This move boosts shareholder value by increasing paid-up capital to ₹11.78 Cr without any fresh fundraising. No other financial or operational updates were declared.